The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Meningitis, Cryptococcal

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Meningitis, Cryptococcal


High impact information on Meningitis, Cryptococcal


Chemical compound and disease context of Meningitis, Cryptococcal


Biological context of Meningitis, Cryptococcal


Anatomical context of Meningitis, Cryptococcal


Gene context of Meningitis, Cryptococcal


Analytical, diagnostic and therapeutic context of Meningitis, Cryptococcal


  1. S-adenosylmethionine concentrations in diagnosis of Pneumocystis carinii pneumonia. Skelly, M., Hoffman, J., Fabbri, M., Holzman, R.S., Clarkson, A.B., Merali, S. Lancet (2003) [Pubmed]
  2. Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Moore, R.D., Chaisson, R.E. Ann. Intern. Med. (1996) [Pubmed]
  3. Progressive multifocal leukoencephalopathy and cryptococcal meningitis with systemic lupus erythematosus and thymoma. Malas, D., Weiss, S. Ann. Neurol. (1977) [Pubmed]
  4. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient. Saiki, O., Shimizu, M., Saeki, Y., Kishimoto, S., Kishimoto, T. J. Immunol. (1984) [Pubmed]
  5. Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis. Stamm, A.M., Diasio, R.B., Dismukes, W.E., Shadomy, S., Cloud, G.A., Bowles, C.A., Karam, G.H., Espinel-Ingroff, A. Am. J. Med. (1987) [Pubmed]
  6. Oral azole drugs as systemic antifungal therapy. Como, J.A., Dismukes, W.E. N. Engl. J. Med. (1994) [Pubmed]
  7. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. Saag, M.S., Powderly, W.G., Cloud, G.A., Robinson, P., Grieco, M.H., Sharkey, P.K., Thompson, S.E., Sugar, A.M., Tuazon, C.U., Fisher, J.F. N. Engl. J. Med. (1992) [Pubmed]
  8. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. Chuck, S.L., Sande, M.A. N. Engl. J. Med. (1989) [Pubmed]
  9. Cryptococcus neoformans mating and virulence are regulated by the G-protein alpha subunit GPA1 and cAMP. Alspaugh, J.A., Perfect, J.R., Heitman, J. Genes Dev. (1997) [Pubmed]
  10. Failure of ketoconazole in cryptococcal meningitis. Perfect, J.R., Durack, D.T., Hamilton, J.D., Gallis, H.A. JAMA (1982) [Pubmed]
  11. Amphotericin versus fluconazole in cryptococcal meningitis. Menichetti, F., Tascini, C. N. Engl. J. Med. (1992) [Pubmed]
  12. False negative latex agglutination test in cryptococcal meningitis. Haldane, D.J., Bauman, D.S., Chow, A.W., Doyle, P., Garber, G., Ngui-Yen, J., Smith, J.A. Ann. Neurol. (1986) [Pubmed]
  13. Chronic cryptococcal meningitis: a new experimental model in rabbits. Perfect, J.R., Lang, S.D., Durack, D.T. Am. J. Pathol. (1980) [Pubmed]
  14. The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection. Nelson, M.R., Fisher, M., Cartledge, J., Rogers, T., Gazzard, B.G. AIDS (1994) [Pubmed]
  15. Successful treatment of cryptococcal meningitis with liposomal amphotericin B after failure of treatment with fluconazole and conventional amphotericin B. Coker, R., Tomlinson, D., Harris, J. AIDS (1991) [Pubmed]
  16. Effect of rifampicin on the pharmacokinetics of fluconazole in patients with AIDS. Panomvana Na Ayudhya, D., Thanompuangseree, N., Tansuphaswadikul, S. Clinical pharmacokinetics. (2004) [Pubmed]
  17. Cryptococcal meningitis in pregnancy. Chen, C.P., Wang, K.G. American journal of perinatology. (1996) [Pubmed]
  18. Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications. Lyman, C.A., Walsh, T.J. Drugs (1992) [Pubmed]
  19. In vitro and in vivo efficacies of the new triazole albaconazole against Cryptococcus neoformans. Miller, J.L., Schell, W.A., Wills, E.A., Toffaletti, D.L., Boyce, M., Benjamin, D.K., Bartroli, J., Perfect, J.R. Antimicrob. Agents Chemother. (2004) [Pubmed]
  20. Natural killer cell-mediated cytotoxicity in cryptococcal meningitis. González-Amaro, R., Salazar-González, J.F., Baranda, L., Abud-Mendoza, C., Martínez-Maza, O., Miramontes, M., Moncada, B. Rev. Invest. Clin. (1991) [Pubmed]
  21. IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis. Siddiqui, A.A., Brouwer, A.E., Wuthiekanun, V., Jaffar, S., Shattock, R., Irving, D., Sheldon, J., Chierakul, W., Peacock, S., Day, N., White, N.J., Harrison, T.S. J. Immunol. (2005) [Pubmed]
  22. RAS1 regulates filamentation, mating and growth at high temperature of Cryptococcus neoformans. Alspaugh, J.A., Cavallo, L.M., Perfect, J.R., Heitman, J. Mol. Microbiol. (2000) [Pubmed]
  23. The gene encoding phosphoribosylaminoimidazole carboxylase (ADE2) is essential for growth of Cryptococcus neoformans in cerebrospinal fluid. Perfect, J.R., Toffaletti, D.L., Rude, T.H. Infect. Immun. (1993) [Pubmed]
  24. Tumour necrosis factor (TNF-alpha) and neurological disorders in HIV infection. Mastroianni, C.M., Paoletti, F., Valenti, C., Vullo, V., Jirillo, E., Delia, S. J. Neurol. Neurosurg. Psychiatr. (1992) [Pubmed]
  25. Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia: defective cytokine production and reversal by recombinant interferon- gamma therapy. Netea, M.G., Brouwer, A.E., Hoogendoorn, E.H., Van der Meer, J.W., Koolen, M., Verweij, P.E., Kullberg, B.J. Clin. Infect. Dis. (2004) [Pubmed]
  26. Case of the month: July 1997--diabetic male with transient ischemic attacks. Karpinsky, N.C., Powell, H. Brain Pathol. (1998) [Pubmed]
  27. Is antifungal susceptibility testing useful in guiding fluconazole therapy? Ghannoum, M.A. Clin. Infect. Dis. (1996) [Pubmed]
  28. Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases. French Cryptococcosis Study Group. Dromer, F., Mathoulin, S., Dupont, B., Brugiere, O., Letenneur, L. Clin. Infect. Dis. (1996) [Pubmed]
  29. A retrospective study on the efficacy and safety of amphotericin B in a lipid emulsion for the treatment of cryptococcal meningitis in AIDS patients. Torre, D., Banfi, G., Tambini, R., Speranza, F., Zeroli, C., Martegani, R., Airoldi, M., Fiori, G. J. Infect. (1998) [Pubmed]
  30. Cryptococcal meningitis: treatment of three patients with miconazole. de Wytt, C.N. Med. J. Aust. (1981) [Pubmed]
WikiGenes - Universities